Latest Safety News

Prescient Therapeutics has achieved a key regulatory milestone with the European Medicines Agency granting Orphan Drug Designation for its PTX-100 therapy targeting Cutaneous T-cell Lymphomas, enhancing its commercial and clinical prospects in Europe.

Acusensus Limited has raised its FY26 revenue guidance to $83-$87 million, driven by significant new contracts in the US and New Zealand and expansions in Australia. This upgrade signals strong momentum in the company’s AI-powered road safety enforcement business.

Biotron Limited has launched a $1.5 million non-renounceable rights issue to fund its strategic acquisition of Sedarex Limited and support ongoing drug development programs. The capital raise follows shareholder approval and aims to diversify Biotron’s portfolio with a next-generation general anaesthetic.

Saunders International reported a challenging FY2025 with profit declines amid operational headwinds but strengthened its Water sector presence through the Aqua Metro acquisition. The company projects a stronger FY2026 backed by a record $4 billion pipeline and improved margins.

AVADA Group’s CEO Donald Montgomery outlined a year of operational consolidation and transformation at the 2025 AGM, reporting significant safety improvements and early signs of revenue growth in 2026 despite ongoing market challenges.

AVADA Group reported a 10.5% revenue decline in FY2025 amid operational consolidation and leadership changes, while conducting a strategic review of its New Zealand operations. Despite setbacks, the company remains cautiously optimistic about future growth.

Regis Healthcare reported robust FY25 financial results and outlined ambitious expansion plans targeting 10,000 beds by FY28, while urging urgent government reforms to address the sector’s undersupply of quality aged care.

SRJ Technologies has partnered with CAPSA Engineering in a $23.8 million joint venture to deliver critical electrical asset integrity services for a Middle Eastern National Oil Company, marking a major step in its regional expansion.

Etherstack plc has successfully raised $6.1 million through an institutional placement, positioning the company to fast-track its Home project and enhance its MCPTX IWF technology.

Polymetals Resources has restarted mining and milling at its Endeavor silver zinc mine following a tragic accident, with shipments and exploration activities ramping up.

Tryptamine Therapeutics has enrolled its second patient in a pioneering clinical trial using IV-infused psilocin to treat Binge Eating Disorder, with first dosing scheduled for December and results expected early next year.

TPG Telecom has disclosed a fatal incident linked to outdated Samsung device software blocking emergency Triple Zero calls, while progressing a major capital raising.